Impact of COVID-19 on Drug Shortages

Impact of COVID-19 on Drug Shortages

PI: Katie J. Suda, PharmD, MS
Funding Source: AHRQ
September 2021 - August 2026

The drug supply chain is global and susceptible to disruptive unanticipated events, such as the 2019 Coronavirus (COVID-19) pandemic, but the impact of drug shortages during a global public health emergency and effectiveness of strategies to alleviate drug shortages is unknown. This project will give policymakers real world evidence to plan for future global emergencies, drug shortages at large, and inform national- and international-policy to decrease the impact of drug shortages on patient outcomes.

Read published results from this work

Sum of the parts: Ensuring a resilient global drug supply chain, Infection Control & Hospital Epidemiology, March 29, 2021
Changes in Purchases for Intensive Care Medicines During the COVID-19 Pandemic: A Global Time Series Study, Chest, August 11, 2021
Impact of the COVID-19 Pandemic on Global Anticoagulant Sales: A Cross-Sectional Analysis Across 39 Countries, American Journal of Cardiovascular Drugs, September 2021